FDA Import Refusal SCS-0452929-4/11/1A — AstraZeneca Ltd

AstraZeneca Ltd — FEI 3000191903

The FDA refused shipment SCS-0452929-4/11/1A from AstraZeneca Ltd (United Kingdom) on Aug 17, 2018. The refused product falls under Drugs and Biologics — TAMOXIFEN CITRATE (ANTI-ESTROGEN). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Aug 17, 2018
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
61UNY05 TAMOXIFEN CITRATE (ANTI-ESTROGEN)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.